Pieton Thierry 4

4 · Medtronic plc · Filed Jul 30, 2025

Form 4

Period: 2025-07-28

EVP & Chief Financial Officer

Transactions

Award
Ordinary Shares
2025-07-28+8,699→ 39,958 total
Award
Performance Share Units
2025-07-28+21,747→ 21,747 total
→ Performance Share Unit (21,747 underlying)
Award
Stock Option (Right to Buy)
2025-07-28+61,338→ 61,338 total
Exercise: $91.97Exp: 2035-07-28→ Ordinary Shares (61,338 underlying)

Footnotes (6)

[F1]Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
[F2]Includes 505 shares acquired through dividend reinvestment since the last report filed by the reporting person.
[F3]Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
[F4]Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028.
[F5]The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,747 shares will be issued. If maximum performance metrics are achieved, 43,494 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
[F6]These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

Documents

1 file